Using data available up to the: 2022-03-28
Subnational and national estimates are available to download here.
See our see Methods or our paper for an explanation of how these estimates are derived.
National summary
Summary (estimates as of the 2022-03-28)
Table 1: Latest estimates (as of the 2022-03-28) of the number of confirmed cases by date of infection, the expected change in daily confirmed cases, the effective reproduction number, the growth rate, and the doubling time (when negative this corresponds to the halving time). The median and 90% credible interval is shown for each numeric estimate.| Estimate | |
|---|---|
| New confirmed cases by infection date | 1351 (273 – 5360) |
| Expected change in daily cases | Decreasing |
| Effective reproduction no. | 0.48 (0.2 – 0.87) |
| Rate of growth | -0.16 (-0.26 – -0.037) |
| Doubling/halving time (days) | -4.4 (-19 – -2.7) |
Confirmed cases, their estimated date of report, date of infection, and time-varying reproduction number estimates
Figure 1: A.) Confirmed cases by date of report (bars) and their estimated date of report. B.) Confirmed cases by date of report (bars) and their estimated date of infection. C.) Time-varying estimate of the effective reproduction number (lightest ribbon = 90% credible interval; darker ribbon = the 50% credible interval, darkest ribbon = 20% credible interval). Estimates from existing data are shown up to the 2022-03-28 from when forecasts are shown. These should be considered indicative only. Estimates based on partial data have been adjusted for right truncation of infections. The vertical dashed line indicates the date of report generation. Uncertainty has been curtailed to a maximum of ten times the maximum number of reported cases for plotting purposes.
Subnational breakdown
Figure 2: The results of the latest reproduction number estimates (based on confirmed cases in Belgium, stratified by Region, can be summarised by whether confirmed cases are likely increasing or decreasing. This represents the strength of the evidence that the reproduction number in each region is greater than or less than 1, respectively (see the methods for details).
Table 2: Latest estimates (as of the 2022-03-28) of the number of confirmed cases by date of infection, the effective reproduction number, the rate of growth, and the doubling time (when negative this corresponds to the halving time) in each region. The median and 90% credible interval is shown.
Data availability
- Case counts by date, stratified by region, were constructed from daily data-sets made publicly available by the Sciensano, the Belgian Institute for Health (Abbott et al. 2020).
- Case onset dates were estimated using case counts by date of report and a distribution of reporting delays fitted to an international line-list (Xu et al., n.d.; Abbott et al. 2020).
Limitations
- Line-list data to inform a Belgium specific estimate of the reporting delay was not available. This means that we could also not account for any regional differences.